Allergan, Inc. v. Sandoz Inc, No. 2:09-cv-00097 (E.D. Tex. Dec. 3, 2013)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court is the Amended Motion to Modify the Injunction filed by Defendants Sandoz Inc., Alcon Laboratories, Inc., Alc on Research, Ltd., Alcon, Inc., and Falcon Pharmaceuticals, Ltd. (collectively, “Sandoz”) . (Dkt. No. 258.) Defendants Apotex Inc. and Apotex Corp. join in the first and second ar guments of Sandoz’s Motion. (Dkt. No. 289.) After considering the parties’ written submissions, the Court DENIES Defendants’ Motion. II.